Literature DB >> 26263935

Outcome after conservatively managed intracapsular fractures of the femoral neck.

L S Moulton1, N L Green2, T Sudahar3, N K Makwana3, J P Whittaker3.   

Abstract

INTRODUCTION: In 2012, 2.6% of hip-fracture patients in the UK were treated conservatively. There is little data on outcome for these patients. However, one study demonstrated that though 30-day mortality is higher, mortality over the rest of the year is comparable with that in surgical groups. Therefore, we assessed conservatively managed patients in our unit.
METHODS: Patients with intracapsular fractures of the femoral neck treated by conservative means between 2010 and 2012 inclusive were identified. Data were collected: American Society of Anaesthesiologists (ASA) grade, Nottingham Hip Fracture Score (NHFS), mobility, mortality (30 days and one year) and pain levels.
RESULTS: Thirty-two patients formed the study cohort. Mean age was 85.6 years. Median ASA grade was 4. Mortality at 30 days and one year was 31.3% and 56.3%, respectively. There was one case of pneumonia and one of infection. Pressure sores or venous thromboembolism were not documented. Three patients underwent surgery once their health improved. In general, mobility was decreased, but 30.8% of patients could mobilise with two aids or a frame. Only two cases had ongoing problems with pain.
CONCLUSIONS: Our data are similar to those published previously. Our patients were likely to have higher mortality data due to selection bias. Thirty-day mortality was significantly higher than the national average, but patients surviving 30 days had a prevalence of mortality similar to those managed by surgical means. Despite mobility decreasing from the pre-admission status, a considerable number of patients were free of pain and could mobilise. These data suggest that conservative management of intracapsular fractures of the femoral neck can produce acceptable results.

Entities:  

Keywords:  Conservative management; Intracapsular fracture; Mortality; Outcome; Pain control

Mesh:

Year:  2015        PMID: 26263935      PMCID: PMC4473865          DOI: 10.1308/003588415X14181254788809

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  6 in total

1.  Survival following hip fracture. Long follow-up of 607 patients.

Authors:  R K Beals
Journal:  J Chronic Dis       Date:  1972-04

2.  Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre.

Authors:  Nicole Williams; Ben M Hardy; Seth Tarrant; Natalie Enninghorst; John Attia; Christopher Oldmeadow; Zsolt J Balogh
Journal:  Arch Osteoporos       Date:  2013-09-19       Impact factor: 2.617

3.  One-year outcome for elderly patients with displaced intracapsular fractures of the femoral neck managed non-operatively.

Authors:  J J Gregory; K Kostakopoulou; W P Cool; D J Ford
Journal:  Injury       Date:  2010-07-13       Impact factor: 2.586

4.  Factors which influence mortality after subcapital hip fracture.

Authors:  D J Wood; G K Ions; J M Quinby; D W Gale; J Stevens
Journal:  J Bone Joint Surg Br       Date:  1992-03

Review 5.  Conservative versus operative treatment for hip fractures in adults.

Authors:  Helen H G Handoll; Martyn J Parker
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

6.  Outcomes following fractured neck of femurin an Australian metropolitan teaching hospital.

Authors:  P H Chia; L Gualano; S Seevanayagam; L Weinberg
Journal:  Bone Joint Res       Date:  2013-08-15       Impact factor: 5.853

  6 in total
  10 in total

1.  Mortality Following Hip Fracture Surgery During COVID-19 Pandemic Compared to Pre-COVID-19 Period: A Case Matched Cohort Series.

Authors:  C De; P K Harbham; C Postoyalko; B Bhavanasi; V Paringe; K Theivendran
Journal:  Malays Orthop J       Date:  2021-07

2.  Clinical Faceoff: When Should Patients 65 Years of Age and Older Have Surgery for Hip Fractures, and When is it a Bad Idea?

Authors:  Lisa K Cannada; Simon C Mears; Carmen Quatman
Journal:  Clin Orthop Relat Res       Date:  2021-01-01       Impact factor: 4.755

3.  Do we need orthogeriatrics in Poland? Changes in the age structure and location of hip fractures.

Authors:  Robert Wilk; Michał Skrzypek; Małgorzata Kowalska; Damian Kusz; Bogdan Koczy; Piotr Zagórski; Wojciech Pluskiewicz
Journal:  Aging Clin Exp Res       Date:  2016-09-06       Impact factor: 3.636

4.  Charlson Comorbidity Index Predicts 5-Year Survivorship of Surgically Treated Hip Fracture Patients.

Authors:  Lei Jiang; Andrew Chia Chen Chou; Nivedita Nadkarni; Caris En Qi Ng; Yun San Chong; Tet Sen Howe; Joyce Suang Bee Koh
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-11-21

5.  Palliative Care in the Hip Fracture Patient.

Authors:  Nicole M Sullivan; Lindsay E Blake; Masil George; Simon C Mears
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-05-30

6.  Femoral Neck Fracture in a Hemodialysis Patient after Liver Transplantation: A Case Report.

Authors:  Satoshi Kamada; Naoki Kise; Koichi Kinoshita; Etsuji Shiota; Takuaki Yamamoto
Journal:  Prog Rehabil Med       Date:  2021-01-22

7.  Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study.

Authors: 
Journal:  BMJ Open       Date:  2021-11-30       Impact factor: 2.692

8.  Effect of Nonsurgical Versus Surgical Management on Geriatric Hip Fracture Mortality of Hispanic-American Male Veterans.

Authors:  Lucas G De Virgilio-Salgado; Gerardo Olivella; Henry Ruberté; Ricardo J Abreu; Antonio Otero-López; Pedro Reyes-Martínez; Norman Ramírez; Francisco Otero-López
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-10-01

9.  Mortality rates of hip fracture patients with non-operative treatment.

Authors:  Joonha Lee; Keun-Young Shin; Hyun-Wook Nam; Minyoung Oh; Gi Sung Shim
Journal:  Jt Dis Relat Surg       Date:  2022-03-28

10.  Nonoperative hip fracture management practices and patient survival compared to surgical care: an analysis of Estonian population-wide data.

Authors:  Pärt Prommik; Kaspar Tootsi; Toomas Saluse; Aare Märtson; Helgi Kolk
Journal:  Arch Osteoporos       Date:  2021-06-25       Impact factor: 2.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.